Hutchens T W, McNaught R W, Yip T T, Suzuki T, Li C M, Besch P K
Department of Obstetrics and Gynecology, Baylor College of Medicine, Texas.
Mol Endocrinol. 1990 Feb;4(2):255-67. doi: 10.1210/mend-4-2-255.
A new antiestrogen affinity ligand for the covalent labeling of estrogen receptors, [3H]desmethylnafoxidine aziridine, has been used to investigate the salt- and temperature-independent formation of DNA-binding estrogen receptor forms from untransformed (300 kilodaltons) receptor. Calf uterine estrogen receptor proteins labeled with [3H]estradiol or [3H]desmethylnafoxidine aziridine were quantitatively transformed (greater than 90%) to their DNA-binding configuration in low ionic strength buffers by brief exposure to 3 M urea at 0 C. The urea effect was hormone-dependent and partially reversible. The transformed receptors were purified (ca 250-fold) by affinity chromatography on single-stranded DNA-agarose in the continued presence of 3 M urea to prevent transformation reversal. Scatchard analyses revealed a single class of high affinity radioligand binding sites (Kd = 0.34 nM) unchanged by urea-induced transformation and purification. The DNA-binding receptor form labeled with [3H]desmethylnafoxidine aziridine was stable as a probable dimer in 3 M urea with 0.4 M KCl and displayed no evidence of size (Stokes radius 7.3 to 7.5 nm; 4.2 to 4.3 S; Mr = 136,800) heterogeneity. Sodium dodecyl sulfate-polyacrylamide gradient gel electrophoresis indicated the presence of an intact 67 kDa steroid-binding receptor subunit. Reverse-phase chromatography of the covalently labeled receptor on C4 and phenyl stationary phases revealed no evidence of structural heterogeneity. The surface charge of the estrogen- and antiestrogen-receptor complexes, however, was distinctly different in both the presence and absence of 3 M urea. Thus, exposure to urea was an effective salt- and temperature-independent means for achieving the complete transformation of receptor to its stable DNA-binding dimer configuration. The ligand-induced differences in receptor surface charge and the urea effects on DNA-binding (but not hormone-binding) suggest that both electrostatic and hydrophobic or hydrogen bonding receptor domains are influenced by ligand binding.
一种用于雌激素受体共价标记的新型抗雌激素亲和配体,即[3H]去甲基萘福昔定氮丙啶,已被用于研究未转化的(300千道尔顿)受体形成与盐和温度无关的DNA结合雌激素受体形式。用[3H]雌二醇或[3H]去甲基萘福昔定氮丙啶标记的小牛子宫雌激素受体蛋白,通过在0℃下短暂暴露于3M尿素,在低离子强度缓冲液中定量转化(大于90%)为其DNA结合构型。尿素效应是激素依赖性的,且部分可逆。在持续存在3M尿素的情况下,通过单链DNA-琼脂糖亲和色谱法纯化转化后的受体(约250倍),以防止转化逆转。Scatchard分析显示存在一类高亲和力放射性配体结合位点(Kd = 0.34 nM),其不受尿素诱导的转化和纯化影响。用[3H]去甲基萘福昔定氮丙啶标记的DNA结合受体形式在含有0.4M KCl的3M尿素中作为可能的二聚体是稳定的,并且没有显示出大小(斯托克斯半径7.3至7.5nm;4.2至4.3S;Mr = 136,800)异质性的证据。十二烷基硫酸钠-聚丙烯酰胺梯度凝胶电泳表明存在完整的67kDa类固醇结合受体亚基。在C4和苯基固定相上对共价标记的受体进行反相色谱分析,没有发现结构异质性的证据。然而,无论是否存在3M尿素,雌激素和抗雌激素受体复合物的表面电荷都明显不同。因此,暴露于尿素是一种有效的、与盐和温度无关的方法,可使受体完全转化为其稳定的DNA结合二聚体构型。配体诱导的受体表面电荷差异以及尿素对DNA结合(而非激素结合)的影响表明,静电和疏水或氢键受体结构域均受配体结合的影响。